LCK and endometrioid tumor: CD55 was found to be highly expressed in CSCs in endometrioid tumors, and it can induce DNA repair through ROR2/JNK and lymphocyte-specific protein tyrosine kinase (LCK) signaling, leading to cisplatin resistance [92].